about
Advanced Stent Graft Treatment of Venous Stenosis Affecting Hemodialysis Vascular Access: Case Illustrations.Validity of Newborn Clinical Assessment to Determine Gestational Age in Bangladesh.Root Cause Analysis of Rebleeding Events following Transjugular Intrahepatic Portosystemic Shunt Creation for Variceal Hemorrhage.Liver Infarction after Drug-Eluting Embolic Transarterial Chemoembolization for Hepatocellular Carcinoma in the Setting of a Large Portosystemic Shunt.Liver Track Embolization After Islet Cell Transplant: Comparison of Two Techniques.Safety and Efficacy of Doxorubicin Drug-Eluting Embolic Chemoembolization of Hepatocellular Carcinoma Supplied by Extrahepatic Collateral Arteries.Quality Improvement Guidelines for Transarterial Chemoembolization and Embolization of Hepatic Malignancy.Gastric Varices Bleed at Lower Portosystemic Pressure Gradients than Esophageal Varices.Liver Masses: What Physicians Need to Know About Ordering and Interpreting Liver Imaging.Albumin-Bilirubin and Platelet-Albumin-Bilirubin Grades Accurately Predict Overall Survival in High-Risk Patients Undergoing Conventional Transarterial Chemoembolization for Hepatocellular Carcinoma.Filter Eversion Technique for Removal of Option ELITE Inferior Vena Cava Filters.Does advanced chronic kidney disease impact transjugular intrahepatic portosystemic shunt efficacy and safety?Transjugular Intrahepatic Portosystemic Shunt Creation and Variceal Coil or Plug Embolization Ineffectively Attain Gastric Variceal Decompression or Occlusion: Results of a 26-Patient Retrospective Study.Diagnostic yield of CT urography in the evaluation of young adults with hematuria.Tissue plasminogen activator dose and pulmonary artery pressure reduction in catheter directed thrombolysis of submassive pulmonary embolismInflammatory nodules mimic applicator track seeding after percutaneous ablation of renal tumorsAlbumin-Bilirubin and Platelet-Albumin-Bilirubin Grades Do Not Predict Survival After Transjugular Intrahepatic Portosystemic Shunt CreationArterial-portal fistula treated with hepatic arterial embolization and portal venous aneurysm stent-graft exclusion complicated by type 2 endoleak
P50
Q36716843-00AAF2DD-F498-4883-8E07-9873A206CACBQ37047424-C855B593-B4AD-4DA5-AD72-53802A310FE9Q38560340-61ED27A7-831A-44D3-BD7F-4F5761B0C03BQ39025146-FA35012A-6BB2-45AD-8242-804BD44524BAQ39258406-0E13946B-460F-47DB-845D-7D50E3F79621Q40388356-C31F84C7-F2D9-48AE-B2BA-E97DCF5765E0Q46225841-C854ACE5-6101-4F4A-8FD6-41CAB4711D3CQ49905123-680917DB-ABA1-4D32-B65E-75D41AFFC7BDQ50087916-62426F20-EC9C-49AD-BB39-DA5758B47C73Q50901625-27DDA784-017A-4793-A18F-AA09983AA827Q51084553-D95941D5-4B28-49EE-A3E6-A308D2E219C1Q51737356-C9970D30-AB96-4085-9B1E-54FE747CD346Q52983443-0770B9F4-3F65-4A19-9358-61B361B95D88Q53173989-EC758ADE-3A3A-4C36-9666-3100B15309D4Q64232469-130E7BBE-59EB-4A42-A2F8-E4A7C213D5ECQ81332188-6EE8F278-23E5-4749-82F8-7CAA94FD1CCFQ87997961-5798D6B2-77BA-495E-9AC6-93D14E3E5D5DQ92997499-4CB4F195-301F-4F88-A750-8C609496A087
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
R Peter Lokken
@en
R Peter Lokken
@nl
type
label
R Peter Lokken
@en
R Peter Lokken
@nl
prefLabel
R Peter Lokken
@en
R Peter Lokken
@nl
P31
P496
0000-0003-1669-5188